Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.075 USD | -2.59% | +12.58% | +23.79% |
May. 13 | Oppenheimer Adjusts Achieve Life Sciences Price Target to $11 From $18, Maintains Outperform Rating | MT |
May. 09 | Transcript : Achieve Life Sciences, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+23.79% | 178M | |
+33.28% | 49.46B | |
+1.78% | 42.58B | |
+49.11% | 42.49B | |
-4.22% | 29.09B | |
+11.53% | 26.61B | |
-22.66% | 18.64B | |
+7.98% | 13.16B | |
+29.60% | 12.55B | |
+24.25% | 12.1B |
- Stock Market
- Equities
- ACHV Stock
- News Achieve Life Sciences, Inc.
- Achieve Life Sciences Starts Screening in Late-Stage Trial of Cytisinicline to Quit Smoking